Projects By Category: CNS and GI
Stay up to date with project updates from the CNS and GI category.Latest Industry Projects in CNS and GI
Vyndaqel (Tafamidis) - Treatment for Transthyretin Familial Amyloid Polyneuropathy
Vyndaqel (tafamidis) is a first-in-class transthyretin stabiliser indicated for the treatment of Transthyretin Familial Amyloid Polyneuropathy...
> read more
Vyndaqel (tafamidis) is a first-in-class transthyretin stabiliser indicated for the treatment of Transthyretin Familial Amyloid Polyneuropathy...
> read more
Banzel – Treatment for Lennox-Gastaut syndrome
Banzel (Rufinamide) was developed in 2004 by Novartis Pharma. It is being manufactured by Eisai in Europe. It is indicated for the treatment of epileptic...
Trobalt / Potiga – Treatment for Partial-Onset Seizure
Trobalt (Ezogabine / Retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged...
Seroquel - Treatment for Major Depressive Disorder (MDD)
Seroquel (quetiapine fumarate) is an anti-psychotic drug indicated as an add-on treatment for patients suffering from major depressive disorder (MDD). The drug was developed by...
Change Category
Projects In CNS and GI Alphabetically
- Latuda (lurasidone HCl) for the Treatment of Schizophrenia, United States of America
- Lurasidone - Treatment for Schizophrenia and Bipolar Disorder, Japan
- Lamictal – Approved Treatment for Epilepsy and Bipolar, United States of America
- Lexapro, Other
- LY2140023 – Treatment of Schizophrenia, Other
- Licofelone - Novel Analgesic and Anti-Inflammatory, Other
- Lyrica (Pregabalin) - New Gabapentinoid with Wide, Other
